20,000 postop followed for upto 13 yrs

prettydove
on 6/27/08 8:32 am, edited 7/2/08 7:42 pm
20,000 postop patient of various surgeries were compared to each other. The key word is cure and reduction to provide a control to the disease of diabetes. Justed wanted to share Bariatric Surgery A Systematic Review and Meta-analysis JAMA October 13, 2004 Vol 292, No. 14 source where I obtained info from: http://jama.ama-assn.org/cgi/content/abstract/292/14/1724 http://jama.ama-assn.org/cgi/reprint/292/24/3040.pdf http://jama.ama-assn.org/cgi/content/full/jama;293/14/1728-b Chart and beginning sentence courtesy of Pacific Laparoscopy http://www.paclap.com/news&resources/ourpublications/article /diabetescure.html 

Below is a chart outlining the differences following weight loss surgery in the cure and or reduction of diabetes and other serious morbid obesity related diseases reported by Harvey Buchwald, M.D. in his meta analysis published in 2004. In this study over 20,000 postoperative bariatric patients were followed for up to 13 years.

Obesity Related Illnesses that Improved/Resolved Following Weight Loss Surgery:

  Gastric Band RNY DS
Diabetes Mellitus 47.9% 83.7% 98.9%
Hyperlipidemia 58.9% 96.9% 99.1%
Hypertension 43.2% 67.5% 83.4%
Sleep Apnea 95% 80.4% 92%

From Page 7

Cormorbidity Outcomes Diabetes. When defined as the ability to discontinue all diabetes-related medications and maintain blood glucose levels within the normal range, strong evidence for improvement in type 2 diabetes and impaired glucose tolerance was found across all surgery types. Within studies reporting resolution of diabetes, 1417 (76.8% [meta-analytic mean, 76.8%; 95% CI, 70.7%-82.9%]) of 1846 patients experienced complete resolution. Within studies reporting both resolution and improvement or only improvement of diabetes, 414 (85.4% [meta-analytic mean, 86.0%;95% CI, 78.4%-93.7%]) of 485 (mean change, 71.53 mg/dL; 95% CI, 49.37%-93.69 mg/dL [3.97 mmol/L; 95% CI, 2.74-5.2 mmol/L]; n=296 by meta-analysis) compared with unselected populations (means change, 13.33 mg/dL; 95% CI, 10.81-15.86 mg/dL [0.74 mmol/L; 95% CI, 0.60-0.88 mmol/L]; n-2092 by meta-analysis.

There was a difference in diabetes outcomes analyzed according to the 4 categories of operative procedures. With respect to diabetes resolution, there was a gradation of effect from 98.9% (95% CI, 96.8%-100%) for bioliopancreatic diversion or duodenal switch to  83.7% (95% CI, 77.3%-90.1%) for gastric bypass to 71.6% (95%CI; 55.1%-88.2%) for gastroplasty, and to  47.9 (95% CI, 29.1%-66.7%) for gastric banding.  The percentage of patients with diabetes resolved or improved showed different results (Table 5 [page 9]); this variation from the trend solely for diabetes resolved may be due to the far greater number of patients assessed for this variable (n=85) in the total population.

From Page 10

Resolution of diabetes often occurred days following bariatric surgery, even before marked weight loss was achieved. Resolution of diabetes was more prevalent following the predominantly malabsorptive procedures (bioliopancreatic diversion or duodenal switch) and the mixed/restrictive gastric bypass in contrast to the purely restrictive gastroplasty and gastric banding procedures. In addition, there appeared to be a gradation of diabetes resolution as a function of the operative procedure itself.  98.9% for bioliopancreatic diversion or duodenal switch 83.7% for gastric bypass 71.6% for gastroplasty, and  47.9% for gastric banding.

The putative extent and time relationship of the different operative procedures to diabetes resolution or improvement after bariatric surgery may be related to some of the changes in the gut related hormones. The hormonal milieu, or the relative balance of forgut mediators, is differently affected when the distal stomach is bypass, or a partial gastrectomy is performed, and the enteric contents are separated from the bioliopancreatic stream in the upper small intestinal tract. The study of the impact of the various bariatric procedures on leptin, grehlin, resistin, acylation-stimulating protein, adiponectin, entro-glucagon, cholecystokin, and other gastrointestinal satiety mediators receiving increasing attention.

HW 305 / SW 247 / CW 138 / GW 140 
Great minds discuss ideas.
Average minds discuss events.
Small minds discuss people.
PattyL
on 6/27/08 9:27 am
One of the best!
Beam me up Scottie
on 6/27/08 12:29 pm
it just shows what we already know...the DS is a superior surgery.  God when will people just admit it so we can move on....lol. Scott
(deactivated member)
on 6/27/08 3:10 pm - MD
Hey, if they knew this in 2004, why aren't more surgeons doing the DS?  Thanks for sharing a good article. 
Lloyd S.
on 6/27/08 10:00 pm - Fairborn, OH

More surgeons haven't been trained because insurance wasn't covering it.  Also it is probably more difficult and it hasn't been popular.  Like most business, demand also pushes supply.  As word gets out, this will change.

Lloyd
HW 502/SW469/CW250 - Down 219
Hernia repair and Pannilectomy: 13 March 2009

Most Active
Recent Topics
×